Blueprint Medicines Corporation

11/29/2021 | Press release | Distributed by Public on 11/29/2021 06:05

Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics - Form 8-K